Generative AI Legal Issues: 5 Critical Questions Every Business Must Answer Before Deploying AI Solutions

As generative artificial intelligence transforms how businesses operate, legal questions surrounding AI deployment have become increasingly important. Whether you’re building AI-powered products or integrating third-party AI tools into your workflows, understanding the legal landscape is essential to mitigate risk and maximize value. This guide addresses the most common legal questions our clients face when navigating…

Medical Rescheduling, Recreational Risk: How Schedule III Could Reshape Adult-Use Cannabis

Article by: Raza Lawrence and Ivy Perez-Bader After more than fifty years of classification alongside heroin and LSD, cannabis may soon occupy the same legal category as ketamine and Tylenol with codeine. Following an Executive Order issued by President Trump in December 2025 directing the Attorney General to complete the rescheduling rulemaking process in an expeditious…

Data Privacy and AI in Longevity: Legal Risks Around Predictive Biomarkers and Health Data

Article by: Lonnie Rosenwald and Carla Pareja Paris Artificial intelligence has become central to the longevity industry. Companies increasingly rely on machine-learning models to analyze biomarkers, genomic data, wearable device outputs, and other health-related inputs to predict disease risk, biological age, or therapeutic response. Many tools, such as the new ChatGPT Health product, invite consumers…